|
|
Article: New River Pharmaceuticals Announces Exercise of Co-Promotion Option in the U.S. for NRP104.
- Article from:
- PR Newswire
- Article date:
- July 25, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
RADFORD, Va., July 25 /PRNewswire-FirstCall/ -- New River Pharmaceuticals today announced its first exercise of its right to co-promote NRP104 in the United States (including its territories and possessions). NRP104 is the subject of a collaboration agreement between New River and Shire plc. The co-promotion activities of New River will commence in six months or upon the commercial launch of NRP104, whichever occurs later. In exercising its option to co-promote NRP104, New River committed to co-promote the product for at least 24 months and to provide 25% of the total details for the product during the 24-month period.
About New River
New River ...